Enanta Pharmaceuticals (ENTA) Receivables - Other (2012 - 2015)
Enanta Pharmaceuticals' Receivables - Other came in at $1.01 million for fiscal Q1 2016 (quarter ended Dec 31, 2015), down 46.4% from $1.88 million a year earlier but up 133.0% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Receivables - Other (2012 - 2015) Analysis & Trends
At the end of FY2015 (ended Sep 30, 2015), Enanta Pharmaceuticals' Receivables - Other was $433,000, down 84.4% from FY2014.
- Receivables - Other carries a three-year compound annual growth rate of -38.8% (FY2012 to FY2015).
- Going back by fiscal year, Receivables - Other was $2.77 million in FY2014 (+253.3%), $784,000 in FY2013 (-58.6%) and $1.89 million in FY2012.
- The five-year range for quarterly Receivables - Other is $433,000 (fiscal Q4 2015) to $2.77 million (fiscal Q4 2014).
- Year-over-year, Receivables - Other has declined for four consecutive quarters, with growth averaging 52.7% over the last eight quarters.
- The fastest year-over-year change in Receivables - Other over five years came in fiscal Q4 2014 (growth of 253.3%), and the weakest in fiscal Q4 2015 (a decline of 84.4%).
- Business Quant data shows ENTA's Receivables - Other at $433,000 (Q4 2015), $1.38 million (Q3 2015) and $1.55 million (Q2 2015) in the three fiscal quarters before Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Enanta Pharmaceuticals | 367.20 Mn | -360.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 1.01 Mn |
| Sep 30, 2015 | 433,000.00 |
| Jun 30, 2015 | 1.38 Mn |
| Mar 31, 2015 | 1.55 Mn |
| Dec 31, 2014 | 1.88 Mn |
| Sep 30, 2014 | 2.77 Mn |
| Jun 30, 2014 | 2.26 Mn |
| Mar 31, 2014 | 1.60 Mn |
| Dec 31, 2013 | 929,000.00 |
| Sep 30, 2013 | 784,000.00 |
| Jun 30, 2013 | 981,000.00 |
| Mar 31, 2013 | 768,000.00 |
| Sep 30, 2012 | 1.89 Mn |
API Access
Enanta Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();